Among targets that have been experimentally validated (Table 2) and that are co-expressed in prefrontal cortex, at least three (VEGFA, BCL2, and DNA methyltransferase 3B) have been previously implicated in depression or suicide [51], [52], [53]. This evidence concerns the gene BCL2 and depressive disorder.